If you have Parkinson’s disease, you’ve probably heard of levodopa (Parcopa, Sinemet). It’s the most common medicine to control Parkinson’s symptoms, although there are many others that ...

Until now, levodopa has been the standard first-line treatment for Parkinson’s patients. Levodopa — which is converted into dopamine in the brain and targets the D2/D3/D4 dopamine receptors ...

There have been many remarkable changes in treatments for Parkinson's disease in recent years. Scientists have developed new drugs, and they have a better understanding of how to use older treatments.

A clinical trial is underway in Middle Tennessee testing whether a pill can help reduce involuntary muscle movements in ...

Treatment of Parkinson's disease is in large part based on the administration of levodopa. The use of this drug is limited by the development of psychiatric complications, including a disorder ...

As multiple drugmakers race to bring novel, levodopa-based Parkinson’s disease treatments to the market, New Jersey’s Amneal Pharmaceuticals has taken home the gold in the U.S. Late Wednesday ...

The standard medication levodopa does not always work against tremors in Parkinson's disease, especially in stressful situations. Propranolol, however, does work during stress, providing insight ...

Until now, levodopa has been the standard first-line treatment for Parkinson’s patients. Levodopa — which is converted into dopamine in the brain and targets the D2/D3/D4 dopamine receptors ...

L-dopa, or Levodopa, is still a mainstay treatment for Parkinson’s disease, especially in the early stages, said Dr. Kotagal. It can help patients with their speed of walking and fine motor ...